Ovarian Disorders Flashcards
1
Q
Ovarian Cyst
A
-
Definition:
- fluid filled sac within the ovaries most commonly related to ovulation. Most common during reproductive years
-
Types:
- Follicular: most common, occur when follicles fail to rupture & continue to grow
- Corpus luteal: fail to degenerate after ovulation
-
S/sxs:
- most are asymptomatic
- may have lower abd pain, dyspareunia
-
PE:
- unilateral pelvic pain/tenderness
- mobile palpable cystic adnexal mass
-
Dx:
- Transvaginal US: follicular are smooth & thin walled, corpus luteal are complex & Thicker walled
- hCG to r/o pregnancy
-
Tx:
- Most resolve spontaneously in a few weeks
- Premenopausal: cycle suppression to prevent them from happening
- Simple cyst: supportive (rest, NSAIDs,) with repeat US
- Loculated cyst: check CA-125 (for malignancy) & refer to GYN
- *Cysts in postmenopausal women are malignant until proven otherwise
2
Q
Ruptured Ovarian Cyst
A
-
S/sxs:
- *Sudden onset
- Unilateral lower abd pain: sharp, focal, may occur during sexual activity
- Abnormal uterine bleeding
-
Pe:
- unilateral pelvic pain/tenderness
- mobile palpable cystic adnexal mass (sometimes)
-
Dx:
- Transvaginal US: adnexal mass & pelvic fluid
- hCG to r/o pregnancy
-
Tx:
- uncomplicated: Observation, analgesics, rest
- Significant hemoperitoneum: hospitalization, observation, fluid replacement
- Unstable: laparoscopy, cystectomy
3
Q
Polycystic Ovarian Syndrome: definition, pathophys, comorbidities, epidemiology
A
-
Definition:
- hormonal disorder among women of reproductive age characterized by bilateral cystic ovaries (sometimes but not always), insulin resistance, & hyperandrogenism
-
Pathophys:
- increased LH -→ increased testosterone production; decreased FSH → follicular degeneration & decreased ovulation which causes bilateral cystic ovaries
-
Comorbidities:
- infertility, endometrial carcinoma, abnormal uterine bleeding, obesity (50%), emotional risks, virilization syndrome, metabolic syndrome, DMII, OSA, CV disease, HTN, NASH
-
Epidemiology:
- most common endocrine condition in women age 18-44yo, affects ~7% of women in the US (`28% in obese women), ~7%5 of all cases of anovulatory infertility
4
Q
Polycystic Ovarian Syndrome: S/sxs & PE
A
-
S/sxs:
- increased androgens:
- hirsutism, cystic acne, alopecia, baldness, voice deepening, increased muscle mass, clitoromegaly
- menstrual dysfunction:
- oligomenorrhea (cycles > 35 days), amenorrhea (absence of menstruation for 6-12 months) or menorrhagia (heavy or prolonged bleeding
- Insulin resistance: DM II,obesity, HTN
- increased androgens:
-
PE:
- Skin:
- Jawline, back and chest cystic acne
- Hair:
- hirsutism (face, posterior back, abdomen), androgenic alopecia
- Acanthosis Nigricans
- Central Adiposity:
- apple-shaped body
- Bilaterally enlarged, smooth, mobile ovaries on bimanual examination→ “string of pearls” appearance
- Skin:
5
Q
Polycystic Ovarian Syndrome: Dx & Tx
A
-
Dx:
- labs to order:
- free testosterone -→ increased; sex hormone binding globulin → decreased
- LH/FSH ratio: > 2
- A1C, fasting glucose, 2H OGTT
- UPT to r/o pregancy
- TSH to r/o thyroid disorder; Prolactin to r/o prolactinoma; 17-hydroxyprogesterone to r/o congenital adrenal hyperplasia
- labs to order:
Pelvic US:
- -12+ follicles 2-9mm in diameter or ovary with a volume >10mL
- -”String of pearls” appearance
- *if pt does not want an US (invasive) can get anti-Mullerian Hormone (AMH): if > 4.5 this is diagnostic for PCOS
Hyperandrogenism: baseline for diagnosis
- -Oligomenorrhea
- -Polycystic ovaries
- *diagnostics SUPPORT dx but are not necessary
Tx if pregnancy NOT desired:
- -lifestyle changes: diet, exercise, weight loss
- -Oral contraception = mainstay
- -Metform=gold standard, use prophylactically
- -Anti-androgenic agent: spironolactone
- -Hirsutism: electrolysis & light based therapies, spironolactone (teratogenic→caution)
Tx if pregnancy is desired:
- -Clomiphene citrate or letrozole: causes ovulation, but requires a lot of monitoring (refer to OBGYN)
- -metformin: may improve menstrual frequency
6
Q
Ovarian Torsion
A
-
Definition:
- complete or partial rotation of the ovary on its ligamental supports → compromise in ovarian blood flow → infarction
-
Etiology:
- usually a mechanical cause in pts with functional ovarian cysts or ovarian neoplasms (esp if >5cm)
-
S/sxs:
- acute onset
- unilateral pelvic pain
- N/V
-
PE:
- abd tenderness
- adnexal mass
-
Dx:
- US with doppler = initial test of choice, decreased ovarian blood flow
-
Tx:
- Laparoscopy with detorsion → restores blood flow to ovary
- Salpingo-oophorectomy if the ovary has been hypoperfused for too long and has become necrotic or if malignant tissue is present.
7
Q
Ovarian Cancer (Ovarian Adenocarcinoma)
A
-
Types:
- Epithelial Cell = most common
-
Etiology:
- genetic susceptibility (15%): BRCA1 & BRCA2, HNPCC
- Spontaneous somatic mutation (85%)
-
S/sxs:
- rarely symptomatic until late in disease course
- abd bloating & distension
- changes in bowel/bladder fxn
- anorexia, ascites
- Can’t button top of pants
-
PE:
- Sister Mary Joseph sign: palpable nodule bulging into the umbilical as a result of metastasis of a malignant cancer in the pelvis or abdomen
- If you can feel an ovary in a postmenopausal woman that is cancer until proven otherwise
-
Staging:
- IA: growth limited to one ovary
- IB: growth limited to both ovaries
- IC: tumor limited to one or both ovaries
-
Dx:
- CT scan, Fagotti score: laparoscopic assessment
-
Monitoring Progression:
- CA-124 (biochemical), imaging (CT/PET), PE, increase symptoms
-
Tx:
-
Primary tumor reductive surgery (PDS):
- surgery → chemotherapy (optimal = no residual cancer > 1cm)
-
Neoadjuvant chemotherapy (NACT):
- chemotherapy → surgery → chemotherapy
-
Biologic therapies:
- alter how cancer cells function
- Chemotherapy:
- Carboplatin, taxol (Paclitaxel) IV q 3weeks x 6 treatments
- *Cancer will recur → becomes a chronic disease
-
Primary tumor reductive surgery (PDS):
8
Q
Protective Factors Against Ovarian Cancer
A
Tubal ligation, hysterectomy, multiple pregnancies, pregnancy before 35 yo, OCPs, reduced number of ovulatory cycles